Filing Details

Accession Number:
0001179110-20-007025
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-05 16:34:22
Reporting Period:
2020-06-03
Accepted Time:
2020-06-05 16:34:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1320414 Select Medical Holdings Corp SEM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168882 F Martin Jackson C/O Select Medical Holdings Corporation
4714 Gettysburg Road
Mechanicsburg PA 17055
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-06-03 49,745 $17.08 1,601,953 No 4 S Direct
Common Stock Disposition 2020-06-04 50,255 $17.11 1,551,698 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,634 Indirect By son
Common Stock 2,634 Indirect By son
Common Stock 2,634 Indirect By daughter
Common Stock 2,634 Indirect By son
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.96 to $17.27, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.28, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.